Looks like you’re on the UK site. Choose another location to see content specific to your location
UK ‘failing to invest enough in antimicrobial resistance research’
Not enough is being done by the UK medical research sector to tackle the emergence of antimicrobial resistance, according to a new study led by University College London.
The first systematic analysis of funding for infectious disease research in the UK between 1997 and 2010 has revealed that of the 6,165 studies carried out during this period, 337 were funded for antimicrobial resistance research – only 5.5 percent of the overall total.
In funding terms, these studies accounted for 102 million pounds of the 2.6 billion pound total, equivalent to a 3.9 percent share.
This suggests that more money needs to be spent on finding solutions to this significant global health challenge, given the mounting threat that drug-resistant superbugs such as E. coli pose.
Professor Rifat Atun from Imperial College London said: "Failure to invest in antimicrobial research means we are poorly prepared to manage the rising drug resistant infections with major health and economic consequences."
This study has been published in the same week that a five-year antimicrobial resistance strategy was outlined by the Department of Health, which incorporates both national and international action.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard